Literature DB >> 29874212

Hong Kong stock exchange opens to biotechs.

Shannon Ellis.   

Abstract

Year:  2018        PMID: 29874212     DOI: 10.1038/nbt0618-482

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN: 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  1 in total

1.  Chinese approval for Ascletis' HCV drug is first homegrown success.

Authors:  Shannon Ellis
Journal:  Nat Biotechnol       Date:  2018-08-06       Impact factor: 54.908

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.